INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
22.7K sh
Aug 10, 2026
Page 539 of 1693
← PrevNext →
Aug 10, 2026
traded Aug 10, 2026
+0d
SEC Form 4

Evidence

5
RD
Rico Robert DanielChief Accounting Officer
GLXYGalaxy Digital Inc.
Option exercise
M—
710 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
BS
Benzaquen Jacob ShlomoPrincipal Accounting Officer
VRMVroom, Inc.
Grant or award
A—
7,500 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
CC
Corrales Anna-Lisa ChristinaCLO, CCO, Secretary
VRMVroom, Inc.
Grant or award
A—
22.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
QS
Quinton SashaEVP, Pres. CBG
SCHLSCHOLASTIC CORP
Option exercise
M—
22.2K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

5
Murdoch Keith RupertChairman Emeritus
FOXFox Corp
Grant or award
A—
35.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

5
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
22.7K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

5
RD
Rico Robert DanielChief Accounting Officer
GLXYGalaxy Digital Inc.
Option exercise
M—
18.8K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

5
MA
Modi Rajeev A.SEE REMARKS
ELANElanco Animal Health Inc
Grant or award
A$1,477
67 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

5
RD
Rico Robert DanielChief Accounting Officer
GLXYGalaxy Digital Inc.
Option exercise
M$3,429
710 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

4
PJ
Prahm JeremyChief Investment Officer
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$134K
6,000 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

3
LV
Lee VivieDirector
CVLTCOMMVAULT SYSTEMS INC
Grant or award · 10b5-1 plan
A—
1,761 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

3
AW
Albers Jeffrey W.Director
SYRESpyre Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
5,000 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

2
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Grant or award
A—
141.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

2
AW
Albers Jeffrey W.Director
SYRESpyre Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$52K
5,000 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

2
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Option exercise
M—
5,908 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

2
AD
Agarwal DeveshChief Operating Officer
BANDBandwidth Inc.
Option exercise
M—
7,370 sh
Aug 8, 2026Aug 10, 2026
traded Aug 8, 2026
+2dSEC Form 4

Evidence

2
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Option exercise
M—
141.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

2
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Grant or award
A—
27.7K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

2
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Option exercise
M—
5,908 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

1
RY
Rozenberg Haine YaelVP Finance
VLNValens Semiconductor Ltd.
Open-market sale · 10b5-1 plan
SELL$1,063
625 sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

1
BD
Brown Michael DeanDirector, See Remarks
TNLTravel & Leisure Co.
Open-market sale · 10b5-1 plan
SELL$16K
200 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
MJ
Murtagh Nigel JChief Risk Officer
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M—
1,897 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
MJ
Murtagh Nigel JChief Risk Officer
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M$89K
1,897 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
MW
McIntosh Greg WEVP, Chief Commercial Officer
IRMIRON MOUNTAIN INC
Option exercise · 10b5-1 plan
M—
6,839 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
SS
Sankar ShyamSee Remarks
PLTRPalantir Technologies Inc.
Derivative conversion · 10b5-1 plan
C—
35.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
BD
Brown Michael DeanDirector, See Remarks
TNLTravel & Leisure Co.
Option exercise · 10b5-1 plan
M$8,876
200 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
KA
King Ryan ADirector, Co-Founder
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
337.9K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
83.0K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

0
SS
Sankar ShyamSee Remarks
PLTRPalantir Technologies Inc.
Derivative conversion · 10b5-1 plan
C—
35.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
200.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
150.0K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

0
MJ
Murtagh Nigel JChief Risk Officer
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M—
24.8K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

0
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
150.0K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC Form 4

Evidence

0
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
83.0K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

0
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
200.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
49.8K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC Form 4

Evidence

0
FA
Fang AndyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
15.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
FA
Fang AndyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
15.0K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence

0
BD
Brown Michael DeanDirector, See Remarks
TNLTravel & Leisure Co.
Option exercise · 10b5-1 plan
M—
200 sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC Form 4

Evidence